Literature DB >> 21265355

Breast cancer in the young patient.

Jack Sariego1.   

Abstract

Patients under 40 years of age comprise about 5 per cent of the overall breast cancer population. These patients are often considered to have a more aggressive disease and are often treated differently as well. A review was performed of all breast cancer patients reported in the American College of Surgeons Cancer Database from 1998 to 2005. The study cohort included all patients less than 40 years of age. Data collected included stage at time of diagnosis, histologic type, and initial treatment performed. These data were then compared with those of patients age 40 or older. The 70,437 cohort patients identified comprised 5.0 per cent of all breast cancer patients reported. There was a statistically significant difference in stage at the time of presentation: 20 per cent of younger patients presented with advanced disease (stage III or IV) versus 13.5 per cent of older patients. A significantly greater percentage of younger patients also presented with infiltrating ductal carcinoma as opposed to the older population (76.9% vs 67.9%). A significantly greater percentage of young patients was treated with mastectomy when compared with the older population (47.7% vs 36.7%, respectively). This difference persisted even when data were controlled for stage. The younger breast cancer patient presents with more advanced disease, suggesting either a more aggressive disease or a greater delay in diagnosis. Also, at all stages, the young patient tends to be treated more "aggressively" surgically, suggesting that the prevailing concept that breast cancer is a "worse" disease in the young may be directing treatment options and patient choices.

Entities:  

Mesh:

Year:  2010        PMID: 21265355

Source DB:  PubMed          Journal:  Am Surg        ISSN: 0003-1348            Impact factor:   0.688


  26 in total

1.  Integrated analysis of differentially expressed genes in breast cancer pathogenesis.

Authors:  Daobao Chen; Hongjian Yang
Journal:  Oncol Lett       Date:  2015-04-23       Impact factor: 2.967

2.  Identification of differently expressed genes with specific SNP Loci for breast cancer by the integration of SNP and gene expression profiling analyses.

Authors:  Pengfei Yuan; Dechun Liu; Miao Deng; Jiangbo Liu; Jianguang Wang; Like Zhang; Qipeng Liu; Ting Zhang; Yanbin Chen; Gaoyuan Jin
Journal:  Pathol Oncol Res       Date:  2014-11-19       Impact factor: 3.201

3.  Indian Solutions for Indian Problems-Association of Breast Surgeons of India (ABSI) Practical Consensus Statement, Recommendations, and Guidelines for the Treatment of Breast Cancer in India.

Authors:  S P Somashekhar; Gaurav Agarwal; S V S Deo; P Raghu Ram; Diptendra Sarkar; Vani Parmar
Journal:  Indian J Surg       Date:  2017-06-22       Impact factor: 0.656

4.  Crystal structure and chemotherapeutic efficacy of the novel compound, gallium tetrachloride betaine, against breast cancer using nanotechnology.

Authors:  Ahmed Salem; Eman Noaman; Eman Kandil; Abdelfattah Badawi; Nihal Mostafa
Journal:  Tumour Biol       Date:  2016-02-19

5.  Frequent loss of the BLID gene in early-onset breast cancer.

Authors:  L R Cavalli; A-M Noone; K H Makambi; J D Rone; U N Kasid; B R Haddad
Journal:  Cytogenet Genome Res       Date:  2011-08-12       Impact factor: 1.636

6.  Reducing time-to-treatment in underserved Latinas with breast cancer: the Six Cities Study.

Authors:  Amelie Ramirez; Eliseo Perez-Stable; Frank Penedo; Gregory Talavera; J Emilio Carrillo; María Fernández; Alan Holden; Edgar Munoz; Sandra San Miguel; Kipling Gallion
Journal:  Cancer       Date:  2013-11-12       Impact factor: 6.860

7.  High Levels of Chromosomal Copy Number Alterations and TP53 Mutations Correlate with Poor Outcome in Younger Breast Cancer Patients.

Authors:  Ayla Koçak; Kerstin Heselmeyer-Haddad; Annette Lischka; Daniela Hirsch; David Fiedler; Yue Hu; Natalie Doberstein; Irianna Torres; Wei-Dong Chen; E Michael Gertz; Alejandro A Schäffer; Sandra Freitag-Wolf; Jutta Kirfel; Gert Auer; Jens K Habermann; Thomas Ried
Journal:  Am J Pathol       Date:  2020-05-13       Impact factor: 4.307

8.  CD44 rs13347 C>T polymorphism predicts breast cancer risk and prognosis in Chinese populations.

Authors:  Lan Jiang; Jieqiong Deng; Xun Zhu; Jian Zheng; Yonghe You; Na Li; Hongchun Wu; Jiachun Lu; Yifeng Zhou
Journal:  Breast Cancer Res       Date:  2012-07-12       Impact factor: 6.466

9.  Relevance of systems biological approach in the differential diagnosis of invasive lobular carcinoma & invasive ductal carcinoma.

Authors:  P K Ragunath; B Vanaja Reddy; P A Abhinand; Shiek S S J Ahmed
Journal:  Bioinformation       Date:  2012-04-30

10.  Dracorhodin perchlorate induced human breast cancer MCF-7 apoptosis through mitochondrial pathways.

Authors:  Jing-hua Yu; Gui-bin Zheng; Chun-yu Liu; Li-ying Zhang; Hong-mei Gao; Ya-hong Zhang; Chun-yan Dai; Lin Huang; Xian-ying Meng; Wen-Yan Zhang; Xiao-fang Yu
Journal:  Int J Med Sci       Date:  2013-07-07       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.